Home-based monitoring of muscle strength in patients with ALS

Home-based monitoring of muscle strength in patients with ALS - Home-based monitoring of muscle strength in patients with ALS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50814

Enrollment

Registered

2021-07-20

Start date

2021-10-12

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Interventions

None listed

Eligibility

Age

16 Years to 64 Years

Inclusion criteria

Inclusion criteria: Is diagnosed with ALS of PMA Has a minimal muscle strength of MRC 3 in at least one leg Sufficient knowledge of the Dutch language to complete the questionnaires Signed informed consent

Exclusion criteria

Exclusion criteria: Severe cognitive impairments Current knee pain

Design outcomes

Primary

Measure	Time frame
The primary outcome is the feasibility (expressed as acceptance and adherence to the 2-weekly assessment of muscle strength measurements using the PFD in the home-situation.	—

Secondary

Measure	Time frame
Secondary outcome is the rate of decline in muscle strength during the follow-up period. The trajectory of independent muscle strength measurements over time will be compared with the Revised ALS Functional Rating Scale (ALSFRS-R).	—

Countries

Netherlands

Outcome results